Comparative analysis of human leucocyte antigen between idiopathic and anti‐PD‐1 antibody induced isolated adrenocorticotropic hormone deficiency: A pilot study
Background Adult‐onset idiopathic isolated adrenocorticotropic hormone deficiency (id‐IAD) is a rare disease with unknown aetiology. Recently, numerous cases of anti‐PD‐1 antibody‐induced IAD (PD1‐IAD) have been reported, but the clinical course, predictive factors and relationship to id‐IAD have no...
Gespeichert in:
Veröffentlicht in: | Clinical endocrinology (Oxford) 2019-12, Vol.91 (6), p.786-792 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 792 |
---|---|
container_issue | 6 |
container_start_page | 786 |
container_title | Clinical endocrinology (Oxford) |
container_volume | 91 |
creator | Inaba, Hidefumi Ariyasu, Hiroyuki Iwakura, Hiroshi Ueda, Yoko Kurimoto, Chiaki Uraki, Shinsuke Takeshima, Ken Yamaoka, Hiroyuki Furukawa, Yasushi Morita, Shuhei Nishi, Masahiro Akamizu, Takashi |
description | Background
Adult‐onset idiopathic isolated adrenocorticotropic hormone deficiency (id‐IAD) is a rare disease with unknown aetiology. Recently, numerous cases of anti‐PD‐1 antibody‐induced IAD (PD1‐IAD) have been reported, but the clinical course, predictive factors and relationship to id‐IAD have not been clarified. Moreover, associations of id‐IAD and PD1‐IAD with human leucocyte antigen (HLA) require elucidation.
Methods
Clinical characteristics of 13 Japanese patients with id‐IAD and eight Japanese patients with PD1‐IAD were analysed, and HLA‐typing test was performed for each patient. Allele and haplotype frequencies of the patients were compared to those of healthy Japanese controls.
Results
In the HLA allele and haplotype analyses of id‐IAD, the frequencies of HLA‐C*14:02, HLA‐DPB1*05:01, HLA‐DRB1*04:05‐DQB1*04:01‐DPB1*05:01 and HLA‐DRB1*09:01‐DQB1*03:03‐DPB1*05:01 were significantly increased. On the other hand, HLA alleles account for PD1‐IAD susceptibility as follows: HLA‐DQB1*06:01, HLA‐DPB1*09:01 and HLA‐DRB5*01:02. Moreover, protective effect for HLA‐C*03:03 was suggested in combined id‐IAD and PD1‐IAD patients. Comparison of the effects of HLA on id‐IAD and PD1‐IAD revealed some differences. Alleles or haplotypes frequencies increased in id‐IAD group were as follows: HLA‐DPB1*05:01, HLA‐DRB1*09:01, HLA‐DRB4*01:03:02, HLA‐DQB1*03:03 and HLA‐DRB1*09:01‐DQB1*03:03. In clinical settings, hyponatremia, disturbance of consciousness and hypoglycaemia were less frequently seen in patients with PD1‐IAD than in patients with id‐IAD.
Conclusions
Distinct clinical characteristics and predisposing HLA allele contributions were proposed between id‐IAD and PD1‐IAD. Further investigations with greater number of cases are warranted to clarify the detailed mechanisms of id‐IAD and PD1‐IAD. |
doi_str_mv | 10.1111/cen.14082 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2283113769</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2315048296</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4192-ccdcaccbbefa60cd3d39858ca4bc947c8754aa5aaf5181d46b57e01da8ceb16e3</originalsourceid><addsrcrecordid>eNp1kU1u1TAUhS0Eoq-FARtAlpjQQVo7sR2HWfUoP1IFDGAcOdc3PFdJHGynVWYsgUWwMlaC-15hgIQHPtc63z0DH0KecXbG8zkHnM64YLp8QDa8UrIoSyUfkg2rGCuYUuKIHMd4zRiTmtWPyVHFhdJS8A35ufXjbIJJ7gapmcywRhep7-luGc1EB1zAw5ruvOS-4kQ7TLeY1VnnZ5N2DrJl9_av7z8-vc4X3786b1fqJrsAWuqiH0zKg7EBJw8-JAc-BT_n_Z0Po5-QWuwdOJxgfUUv6OwGn2hMi12fkEe9GSI-vdcT8uXN5eftu-Lq49v324urAgRvygLAggHoOuyNYmArWzVaajCig0bUoGspjJHG9JJrboXqZI2MW6MBO66wOiEvD7lz8N8WjKkdXQQcBjOhX2JblrrivKpVk9EX_6DXfgn5_zJVccmELhuVqdMDBcHHGLBv5-BGE9aWs_auujZX1-6ry-zz-8SlG9H-Jf90lYHzA3DrBlz_n9RuLz8cIn8DycKpNA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2315048296</pqid></control><display><type>article</type><title>Comparative analysis of human leucocyte antigen between idiopathic and anti‐PD‐1 antibody induced isolated adrenocorticotropic hormone deficiency: A pilot study</title><source>Wiley Online Library - AutoHoldings Journals</source><creator>Inaba, Hidefumi ; Ariyasu, Hiroyuki ; Iwakura, Hiroshi ; Ueda, Yoko ; Kurimoto, Chiaki ; Uraki, Shinsuke ; Takeshima, Ken ; Yamaoka, Hiroyuki ; Furukawa, Yasushi ; Morita, Shuhei ; Nishi, Masahiro ; Akamizu, Takashi</creator><creatorcontrib>Inaba, Hidefumi ; Ariyasu, Hiroyuki ; Iwakura, Hiroshi ; Ueda, Yoko ; Kurimoto, Chiaki ; Uraki, Shinsuke ; Takeshima, Ken ; Yamaoka, Hiroyuki ; Furukawa, Yasushi ; Morita, Shuhei ; Nishi, Masahiro ; Akamizu, Takashi</creatorcontrib><description>Background
Adult‐onset idiopathic isolated adrenocorticotropic hormone deficiency (id‐IAD) is a rare disease with unknown aetiology. Recently, numerous cases of anti‐PD‐1 antibody‐induced IAD (PD1‐IAD) have been reported, but the clinical course, predictive factors and relationship to id‐IAD have not been clarified. Moreover, associations of id‐IAD and PD1‐IAD with human leucocyte antigen (HLA) require elucidation.
Methods
Clinical characteristics of 13 Japanese patients with id‐IAD and eight Japanese patients with PD1‐IAD were analysed, and HLA‐typing test was performed for each patient. Allele and haplotype frequencies of the patients were compared to those of healthy Japanese controls.
Results
In the HLA allele and haplotype analyses of id‐IAD, the frequencies of HLA‐C*14:02, HLA‐DPB1*05:01, HLA‐DRB1*04:05‐DQB1*04:01‐DPB1*05:01 and HLA‐DRB1*09:01‐DQB1*03:03‐DPB1*05:01 were significantly increased. On the other hand, HLA alleles account for PD1‐IAD susceptibility as follows: HLA‐DQB1*06:01, HLA‐DPB1*09:01 and HLA‐DRB5*01:02. Moreover, protective effect for HLA‐C*03:03 was suggested in combined id‐IAD and PD1‐IAD patients. Comparison of the effects of HLA on id‐IAD and PD1‐IAD revealed some differences. Alleles or haplotypes frequencies increased in id‐IAD group were as follows: HLA‐DPB1*05:01, HLA‐DRB1*09:01, HLA‐DRB4*01:03:02, HLA‐DQB1*03:03 and HLA‐DRB1*09:01‐DQB1*03:03. In clinical settings, hyponatremia, disturbance of consciousness and hypoglycaemia were less frequently seen in patients with PD1‐IAD than in patients with id‐IAD.
Conclusions
Distinct clinical characteristics and predisposing HLA allele contributions were proposed between id‐IAD and PD1‐IAD. Further investigations with greater number of cases are warranted to clarify the detailed mechanisms of id‐IAD and PD1‐IAD.</description><identifier>ISSN: 0300-0664</identifier><identifier>EISSN: 1365-2265</identifier><identifier>DOI: 10.1111/cen.14082</identifier><identifier>PMID: 31468541</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Adrenocorticotropic hormone ; Alleles ; Antigens ; antiprogrammed cell death protein 1 antibody ; Cell death ; Comparative analysis ; Drb1 protein ; Gene frequency ; Haplotypes ; Histocompatibility antigen HLA ; human leucocyte antigen ; Hypoglycemia ; Hyponatremia ; immune‐checkpoint inhibitor ; PD-1 protein ; pituitary gland ; Rare diseases ; Tissue typing</subject><ispartof>Clinical endocrinology (Oxford), 2019-12, Vol.91 (6), p.786-792</ispartof><rights>2019 John Wiley & Sons Ltd</rights><rights>2019 John Wiley & Sons Ltd.</rights><rights>Copyright © 2019 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4192-ccdcaccbbefa60cd3d39858ca4bc947c8754aa5aaf5181d46b57e01da8ceb16e3</citedby><cites>FETCH-LOGICAL-c4192-ccdcaccbbefa60cd3d39858ca4bc947c8754aa5aaf5181d46b57e01da8ceb16e3</cites><orcidid>0000-0002-7718-734X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fcen.14082$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fcen.14082$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31468541$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Inaba, Hidefumi</creatorcontrib><creatorcontrib>Ariyasu, Hiroyuki</creatorcontrib><creatorcontrib>Iwakura, Hiroshi</creatorcontrib><creatorcontrib>Ueda, Yoko</creatorcontrib><creatorcontrib>Kurimoto, Chiaki</creatorcontrib><creatorcontrib>Uraki, Shinsuke</creatorcontrib><creatorcontrib>Takeshima, Ken</creatorcontrib><creatorcontrib>Yamaoka, Hiroyuki</creatorcontrib><creatorcontrib>Furukawa, Yasushi</creatorcontrib><creatorcontrib>Morita, Shuhei</creatorcontrib><creatorcontrib>Nishi, Masahiro</creatorcontrib><creatorcontrib>Akamizu, Takashi</creatorcontrib><title>Comparative analysis of human leucocyte antigen between idiopathic and anti‐PD‐1 antibody induced isolated adrenocorticotropic hormone deficiency: A pilot study</title><title>Clinical endocrinology (Oxford)</title><addtitle>Clin Endocrinol (Oxf)</addtitle><description>Background
Adult‐onset idiopathic isolated adrenocorticotropic hormone deficiency (id‐IAD) is a rare disease with unknown aetiology. Recently, numerous cases of anti‐PD‐1 antibody‐induced IAD (PD1‐IAD) have been reported, but the clinical course, predictive factors and relationship to id‐IAD have not been clarified. Moreover, associations of id‐IAD and PD1‐IAD with human leucocyte antigen (HLA) require elucidation.
Methods
Clinical characteristics of 13 Japanese patients with id‐IAD and eight Japanese patients with PD1‐IAD were analysed, and HLA‐typing test was performed for each patient. Allele and haplotype frequencies of the patients were compared to those of healthy Japanese controls.
Results
In the HLA allele and haplotype analyses of id‐IAD, the frequencies of HLA‐C*14:02, HLA‐DPB1*05:01, HLA‐DRB1*04:05‐DQB1*04:01‐DPB1*05:01 and HLA‐DRB1*09:01‐DQB1*03:03‐DPB1*05:01 were significantly increased. On the other hand, HLA alleles account for PD1‐IAD susceptibility as follows: HLA‐DQB1*06:01, HLA‐DPB1*09:01 and HLA‐DRB5*01:02. Moreover, protective effect for HLA‐C*03:03 was suggested in combined id‐IAD and PD1‐IAD patients. Comparison of the effects of HLA on id‐IAD and PD1‐IAD revealed some differences. Alleles or haplotypes frequencies increased in id‐IAD group were as follows: HLA‐DPB1*05:01, HLA‐DRB1*09:01, HLA‐DRB4*01:03:02, HLA‐DQB1*03:03 and HLA‐DRB1*09:01‐DQB1*03:03. In clinical settings, hyponatremia, disturbance of consciousness and hypoglycaemia were less frequently seen in patients with PD1‐IAD than in patients with id‐IAD.
Conclusions
Distinct clinical characteristics and predisposing HLA allele contributions were proposed between id‐IAD and PD1‐IAD. Further investigations with greater number of cases are warranted to clarify the detailed mechanisms of id‐IAD and PD1‐IAD.</description><subject>Adrenocorticotropic hormone</subject><subject>Alleles</subject><subject>Antigens</subject><subject>antiprogrammed cell death protein 1 antibody</subject><subject>Cell death</subject><subject>Comparative analysis</subject><subject>Drb1 protein</subject><subject>Gene frequency</subject><subject>Haplotypes</subject><subject>Histocompatibility antigen HLA</subject><subject>human leucocyte antigen</subject><subject>Hypoglycemia</subject><subject>Hyponatremia</subject><subject>immune‐checkpoint inhibitor</subject><subject>PD-1 protein</subject><subject>pituitary gland</subject><subject>Rare diseases</subject><subject>Tissue typing</subject><issn>0300-0664</issn><issn>1365-2265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kU1u1TAUhS0Eoq-FARtAlpjQQVo7sR2HWfUoP1IFDGAcOdc3PFdJHGynVWYsgUWwMlaC-15hgIQHPtc63z0DH0KecXbG8zkHnM64YLp8QDa8UrIoSyUfkg2rGCuYUuKIHMd4zRiTmtWPyVHFhdJS8A35ufXjbIJJ7gapmcywRhep7-luGc1EB1zAw5ruvOS-4kQ7TLeY1VnnZ5N2DrJl9_av7z8-vc4X3786b1fqJrsAWuqiH0zKg7EBJw8-JAc-BT_n_Z0Po5-QWuwdOJxgfUUv6OwGn2hMi12fkEe9GSI-vdcT8uXN5eftu-Lq49v324urAgRvygLAggHoOuyNYmArWzVaajCig0bUoGspjJHG9JJrboXqZI2MW6MBO66wOiEvD7lz8N8WjKkdXQQcBjOhX2JblrrivKpVk9EX_6DXfgn5_zJVccmELhuVqdMDBcHHGLBv5-BGE9aWs_auujZX1-6ry-zz-8SlG9H-Jf90lYHzA3DrBlz_n9RuLz8cIn8DycKpNA</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Inaba, Hidefumi</creator><creator>Ariyasu, Hiroyuki</creator><creator>Iwakura, Hiroshi</creator><creator>Ueda, Yoko</creator><creator>Kurimoto, Chiaki</creator><creator>Uraki, Shinsuke</creator><creator>Takeshima, Ken</creator><creator>Yamaoka, Hiroyuki</creator><creator>Furukawa, Yasushi</creator><creator>Morita, Shuhei</creator><creator>Nishi, Masahiro</creator><creator>Akamizu, Takashi</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7718-734X</orcidid></search><sort><creationdate>201912</creationdate><title>Comparative analysis of human leucocyte antigen between idiopathic and anti‐PD‐1 antibody induced isolated adrenocorticotropic hormone deficiency: A pilot study</title><author>Inaba, Hidefumi ; Ariyasu, Hiroyuki ; Iwakura, Hiroshi ; Ueda, Yoko ; Kurimoto, Chiaki ; Uraki, Shinsuke ; Takeshima, Ken ; Yamaoka, Hiroyuki ; Furukawa, Yasushi ; Morita, Shuhei ; Nishi, Masahiro ; Akamizu, Takashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4192-ccdcaccbbefa60cd3d39858ca4bc947c8754aa5aaf5181d46b57e01da8ceb16e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adrenocorticotropic hormone</topic><topic>Alleles</topic><topic>Antigens</topic><topic>antiprogrammed cell death protein 1 antibody</topic><topic>Cell death</topic><topic>Comparative analysis</topic><topic>Drb1 protein</topic><topic>Gene frequency</topic><topic>Haplotypes</topic><topic>Histocompatibility antigen HLA</topic><topic>human leucocyte antigen</topic><topic>Hypoglycemia</topic><topic>Hyponatremia</topic><topic>immune‐checkpoint inhibitor</topic><topic>PD-1 protein</topic><topic>pituitary gland</topic><topic>Rare diseases</topic><topic>Tissue typing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Inaba, Hidefumi</creatorcontrib><creatorcontrib>Ariyasu, Hiroyuki</creatorcontrib><creatorcontrib>Iwakura, Hiroshi</creatorcontrib><creatorcontrib>Ueda, Yoko</creatorcontrib><creatorcontrib>Kurimoto, Chiaki</creatorcontrib><creatorcontrib>Uraki, Shinsuke</creatorcontrib><creatorcontrib>Takeshima, Ken</creatorcontrib><creatorcontrib>Yamaoka, Hiroyuki</creatorcontrib><creatorcontrib>Furukawa, Yasushi</creatorcontrib><creatorcontrib>Morita, Shuhei</creatorcontrib><creatorcontrib>Nishi, Masahiro</creatorcontrib><creatorcontrib>Akamizu, Takashi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical endocrinology (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Inaba, Hidefumi</au><au>Ariyasu, Hiroyuki</au><au>Iwakura, Hiroshi</au><au>Ueda, Yoko</au><au>Kurimoto, Chiaki</au><au>Uraki, Shinsuke</au><au>Takeshima, Ken</au><au>Yamaoka, Hiroyuki</au><au>Furukawa, Yasushi</au><au>Morita, Shuhei</au><au>Nishi, Masahiro</au><au>Akamizu, Takashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative analysis of human leucocyte antigen between idiopathic and anti‐PD‐1 antibody induced isolated adrenocorticotropic hormone deficiency: A pilot study</atitle><jtitle>Clinical endocrinology (Oxford)</jtitle><addtitle>Clin Endocrinol (Oxf)</addtitle><date>2019-12</date><risdate>2019</risdate><volume>91</volume><issue>6</issue><spage>786</spage><epage>792</epage><pages>786-792</pages><issn>0300-0664</issn><eissn>1365-2265</eissn><abstract>Background
Adult‐onset idiopathic isolated adrenocorticotropic hormone deficiency (id‐IAD) is a rare disease with unknown aetiology. Recently, numerous cases of anti‐PD‐1 antibody‐induced IAD (PD1‐IAD) have been reported, but the clinical course, predictive factors and relationship to id‐IAD have not been clarified. Moreover, associations of id‐IAD and PD1‐IAD with human leucocyte antigen (HLA) require elucidation.
Methods
Clinical characteristics of 13 Japanese patients with id‐IAD and eight Japanese patients with PD1‐IAD were analysed, and HLA‐typing test was performed for each patient. Allele and haplotype frequencies of the patients were compared to those of healthy Japanese controls.
Results
In the HLA allele and haplotype analyses of id‐IAD, the frequencies of HLA‐C*14:02, HLA‐DPB1*05:01, HLA‐DRB1*04:05‐DQB1*04:01‐DPB1*05:01 and HLA‐DRB1*09:01‐DQB1*03:03‐DPB1*05:01 were significantly increased. On the other hand, HLA alleles account for PD1‐IAD susceptibility as follows: HLA‐DQB1*06:01, HLA‐DPB1*09:01 and HLA‐DRB5*01:02. Moreover, protective effect for HLA‐C*03:03 was suggested in combined id‐IAD and PD1‐IAD patients. Comparison of the effects of HLA on id‐IAD and PD1‐IAD revealed some differences. Alleles or haplotypes frequencies increased in id‐IAD group were as follows: HLA‐DPB1*05:01, HLA‐DRB1*09:01, HLA‐DRB4*01:03:02, HLA‐DQB1*03:03 and HLA‐DRB1*09:01‐DQB1*03:03. In clinical settings, hyponatremia, disturbance of consciousness and hypoglycaemia were less frequently seen in patients with PD1‐IAD than in patients with id‐IAD.
Conclusions
Distinct clinical characteristics and predisposing HLA allele contributions were proposed between id‐IAD and PD1‐IAD. Further investigations with greater number of cases are warranted to clarify the detailed mechanisms of id‐IAD and PD1‐IAD.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31468541</pmid><doi>10.1111/cen.14082</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-7718-734X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0300-0664 |
ispartof | Clinical endocrinology (Oxford), 2019-12, Vol.91 (6), p.786-792 |
issn | 0300-0664 1365-2265 |
language | eng |
recordid | cdi_proquest_miscellaneous_2283113769 |
source | Wiley Online Library - AutoHoldings Journals |
subjects | Adrenocorticotropic hormone Alleles Antigens antiprogrammed cell death protein 1 antibody Cell death Comparative analysis Drb1 protein Gene frequency Haplotypes Histocompatibility antigen HLA human leucocyte antigen Hypoglycemia Hyponatremia immune‐checkpoint inhibitor PD-1 protein pituitary gland Rare diseases Tissue typing |
title | Comparative analysis of human leucocyte antigen between idiopathic and anti‐PD‐1 antibody induced isolated adrenocorticotropic hormone deficiency: A pilot study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T08%3A08%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20analysis%20of%20human%20leucocyte%20antigen%20between%20idiopathic%20and%20anti%E2%80%90PD%E2%80%901%20antibody%20induced%20isolated%20adrenocorticotropic%20hormone%20deficiency:%20A%20pilot%20study&rft.jtitle=Clinical%20endocrinology%20(Oxford)&rft.au=Inaba,%20Hidefumi&rft.date=2019-12&rft.volume=91&rft.issue=6&rft.spage=786&rft.epage=792&rft.pages=786-792&rft.issn=0300-0664&rft.eissn=1365-2265&rft_id=info:doi/10.1111/cen.14082&rft_dat=%3Cproquest_cross%3E2315048296%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2315048296&rft_id=info:pmid/31468541&rfr_iscdi=true |